Bremelanotide Sq Injection bulk supplier for pharma manufacturers

Bremelanotide Sq Injection 1.75 mg Suppliers & Bulk Manufacturers

Available Forms: Injection(SQ)

Available Strengths: 1.75 mg

Reference Brands: Vyleesi (US)

Bremelanotide is a melanocortin receptor agonist that stimulates pathways involved in sexual desire. It increases blood flow and arousal, helping women with hypoactive sexual desire disorder (HSDD). Benefits include rapid onset, improved libido, enhanced intimacy, and increased confidence, supporting better sexual health and partner satisfaction.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Bremelanotide SQ injection, marketed as Vyleesi, is approved in the US by the FDA for premenopausal women with hypoactive sexual desire disorder (HSDD). In the EU, it remains under review or pending approval. Regulatory approval requires a detailed dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance plans. In the US, the FDA rigorously reviews clinical trial data and manufacturing standards, while the EMA ensures compliance with regional safety and quality requirements.

Bremelanotide Sq Injection — third party manufacturing & bulk supply

Bremelanotide Sq Injection 1.75 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Bremelanotide Sq Injection is supplied as Injection(SQ) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Bremelanotide Sq Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Bremelanotide Sq Injection →

Back to Listing

Frequently Asked Questions

Bremelanotide Sq Injection is listed as Injection(SQ) in 1.75 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Bremelanotide Sq Injection is referenced against Vyleesi (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.